Grupo 27
Farmacia Hospitalaria y Farmacogenómica
Publicaciones (413)
-
Prieto-Romero, A; Ibañez-García, S; García-González, X; Castrodeza, J; Torroba-Sanz, B; Ortiz-Bautista, C; Pascual-Izquierdo, C; Barrio-Gutiérrez, JM; González-Pinto, A; Herranz-Alonso, A; Sanjurjo-Sáez, M.
Bleeding Risk of Anticoagulation Reversal Strategies Before Heart Transplantation: A Retrospective Comparative Cohort Study
Journal of Cardiovascular Development and Disease. 2024; 11(11): [doi:10.3390/jcdd11110366]
-
Francois, O; Thurnherr, EH; Blatrie, C; Cousein, E; Herranz, A; Sadeghipour, F; Bonnabry, P.
Integrating automated dispensing cabinets into the medication dispensing process: feedback from the practice in European hospitals
European Journal of Hospital Pharmacy-Science and Practice. 2024; 32(4): 354-360 [doi:10.1136/ejhpharm-2024-004195]
-
Gómez-Oro C; Latorre MC; Arribas-Poza P; Ibáñez-Escribano A; Baca-Cornejo KR; Gallego-Valle J; López-Escobar N; Mondéjar-Palencia M; Pion M; López-Fernández LA; Mercader-Cidoncha E; Pérez-Milán F; Relloso M.
Progesterone promotes Cxcl2-dependent vaginal neutrophil killing by activating cervical resident macrophage-neutrophil crosstalk.
JCI Insight. 2024; 9(20): Nº de citas: 6 [doi:10.1172/jci.insight.177899]
-
Taladriz-Sender, I; Hernández-Osio, G; Zapata-Cobo, P; Salvador-Martín, S; García-González, X; Balas, A; Sanjurjo-Sáez, M; López-Fernández, LA.
An Inexpensive and Quick Method for Genotyping of HLA Variants Included in the Spanish Pharmacogenomic Portfolio of National Health System
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(20): Nº de citas: 1 [doi:10.3390/ijms252011207]
-
Puig, T; Leache, L; González-Senac, NM; Carreras, E; Gutiérrez-Valencia, M; Losa, L; Revuelta-Herrero, JL; Marrero-Alvarez, P; de Miguel, M; Arredondo, AA; Aranguren, A; Vilariño, A; Ruiz, VE; Fernández, I; Bilbao, J; González-Guerrero, C; del Pino, B; Garin, N.
Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain
BMC Geriatrics. 2024; 24(1): Nº de citas: 2 [doi:10.1186/s12877-024-05308-3]
-
Collado-Borell, R; Gomis-Pastor, M; Rodríguez-Cabezas, M; Parro-Martín, A; Linares-Alarcón, A; Gutiérrez, E; González-Corominas, E; Fernández-Polo, A; Domínguez-Cantero, M; Arrondo-Velasco, A; Morillo-Verdugo, R.
Guide for the efficient and safe delivery of Telepharmacy
Health Policy and Technology. 2024; 13(4): Nº de citas: 3 [doi:10.1016/j.hlpt.2024.100899]
-
Lobo-Rodrígueza, C; Díaz-Redondoc, A; Chamorro-de-Vega, E; Ais-Larisgoiti, A; Ibares-Frias, L; Baniandrés-Rodríguez, O; Menchén, L; González-Fernández, CM.
Experience of patients with immune-mediated inflammatory diseases seen in a multidisciplinary integrated care unit
Journal of Healthcare Quality Research. 2024; 39(5): 283-290 [doi:10.1016/j.jhqr.2024.04.006]
-
Badia, X; Calleja, MA; Escudero-Vilaplana, V; Pérez-Martínez, A; Piñana, JL; Poveda, JL; Vallés, JA.
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD)
Orphanet Journal of Rare Diseases. 2024; 19(1): Nº de citas: 3 [doi:10.1186/s13023-024-03324-5]
-
Amor-García, MA; Chamorro-de-Vega, E; Rodríguez-González, CG; Iglesias-Peinado, I; Moreno-Díaz, R.
Effects of a Pharmacist-Designed Clinical Decision Support System on Antimicrobial Stewardship
Applied Clinical Informatics. 2024; 15(04): 679-688 Nº de citas: 4 [doi:10.1055/a-2341-8823]
-
Somoza-Fernández, B; Escudero-Vilaplana, V; Collado-Borrell, R; Perez-Ramírez, S; Villanueva-Bueno, C; Montero-Antón, MD; Herranz-Alonso, A; Sanjurjo-Saez, M.
Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient
JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2024; 30(7): 1268-1273 Nº de citas: 3 [doi:10.1177/10781552241264530]
-
Costas, DG; Ribed, A; Gimenez-Manzorro, A; Garutti, I; Sanz, FJ; Taladriz-Sender, I; Herrero, S; Rioja, Y; Carrillo, A; Herranz, A; Sanjurjo-Saez, M.
Cost-effectiveness of preoperative pharmaceutical care consultations: a 5-year analysis
European Journal of Hospital Pharmacy-Science and Practice. 2024; 32(3): 220-225 [doi:10.1136/ejhpharm-2024-004222]
-
Escudero-Vilaplana V; Guisado-Gil AB; Santos-Ramos B; Herranz A.
Development and consensus of a dashboard model to evaluate research activity in Spanish Hospital Pharmacy Services.
FARMACIA HOSPITALARIA. 2024; 48 Suppl 1: [doi:10.1016/j.farma.2023.12.007]
-
Escudero-Vilaplana, V; Guisado-Gil, AB; Santos-Ramos, B; Herranz, A.
Development and consensus of a dashboard model to evaluate research activity in Spanish Hospital Pharmacy Services
FARMACIA HOSPITALARIA. 2024; 48: 28-34 [doi:10.1016/j.farma.2024.03.006]
-
Gómez-Costas D; Romero-Jiménez RM; Lobato-Matilla ME; Culebras R; González JA; Herrero-Bermejo S; Herranz-Alonso AM; Sanjurjo-Saez M.
Detection and reduction of errors in parenteral nutrition compounding through gravimetric and product control.
FARMACIA HOSPITALARIA. 2024; 48(3): 116-121 Nº de citas: 1 [doi:10.1016/j.farma.2023.11.007]
-
de Lorenzo-Pinto A; Redondo-Galán C; García-González X; Fernández-Álvarez C; Andueza-Lillo J; Sanjurjo-Sáez M.
Presence of metallic components in transdermal drug delivery systems and risk of skin burns.
FARMACIA HOSPITALARIA. 2024; 48(3): 129-132 [doi:10.1016/j.farma.2023.11.003]
-
Gómez-Costas, D; Romero-Jiménez, RM; Lobato-Matilla, ME; Culebras, R; González, JA; Herrero-Bermejo, S; Herranz-Alonso, AM; Sanjurjo, M.
Detection and reduction of errors in parenteral nutrition compounding through gravimetric and product control
FARMACIA HOSPITALARIA. 2024; 48(3): 116-121 [doi:10.1016/j.farma.2024.02.014]
-
de Lorenzo-Pinto, A; Redondo-Galán, C; García-González, X; Fernández-Alvarez, C; Andueza-Lillo, J; Sanjurjo-Sáez, M.
Presence of metallic components in transdermal drug delivery systems and risk of skin burns
FARMACIA HOSPITALARIA. 2024; 48(3): 129-132 [doi:10.1016/j.farma.2024.02.010]
-
Salvador-Martín S; Rubbini G; Vellosillo P; Zapata-Cobo P; Velasco M; Palomino LM; Clemente S; Segarra O; Moreno-Álvarez A; Fernández-Lorenzo A; Pérez-Moneo B; Montraveta M; Sánchez C; Tolín M; Loverdos I; Fobelo MJ; Navas-López VM; Magallares L; García-Romero R; Torres-Peral R; Rodríguez A; Bossacoma F; Merino-Bohórquez V; Salcedo E; Álvarez R; Dopazo A; Sanjurjo-Sáez M; López-Fernández LA.
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.
BIOMEDICINE & PHARMACOTHERAPY. 2024; 173: 116299-116299 Nº de citas: 4 [doi:10.1016/j.biopha.2024.116299]